INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$323K
1,843 sh
Sep 15, 2026
Page 116 of 481
← PrevNext →
Sep 17, 2026
traded Sep 15, 2026
+2d
SEC Form 4

Evidence

9
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$278K
2,572 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$667K
3,901 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$371K
2,129 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$687K
3,990 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

8
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
400 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

8
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
400 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

8
KJ
Kenneweg JohnSVP, Sales & Product Marketing
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$54K
5,257 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

8
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$685K
18.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

8
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
116 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

8
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$6,100
100 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$72K
700 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$223K
1,308 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
KJ
Kenneweg JohnSVP, Sales & Product Marketing
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$10K
1,000 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
586 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$109K
1,100 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$90K
510 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
1,214 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$333K
60.0K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

4
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$382K
75.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$337K
60.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$341K
60.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
200 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
200 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
400 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
300 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

1
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
3,328 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

1
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$113K
6,657 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

1
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
3,329 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

55
BM
Beaulier Jonathan MeadChief Revenue Officer
SNOWSnowflake Inc.
Open-market sale
SELL$4.13M
12.3K sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

51
ZM
Zhuang MingzheDirector
IBEXIBEX Ltd
Open-market sale
SELL$221K
5,522 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

50
TA
Trofimuk-O'Connor Christina AliceChief Legal Officer
IBEXIBEX Ltd
Open-market sale
SELL$302K
7,500 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

48
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Open-market sale
SELL$256K
768 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

47
TA
Tiran AssafEVP Cross Suez & Atlantic BU
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$93K
3,156 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

44
TA
Tiran AssafEVP Cross Suez & Atlantic BU
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$46K
1,571 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

42
CK
Casteel Julie KChief Sales/Marketing Officer
IBEXIBEX Ltd
Open-market sale
SELL$706K
17.5K sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

39
BD
Ballou-Aares DaniellaDirector
IBEXIBEX Ltd
Open-market sale
SELL$60K
1,500 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

39
IJ
Inson Paul JosephChief People Officer
IBEXIBEX Ltd
Open-market sale
SELL$100K
2,500 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

39
TA
Trofimuk-O'Connor Christina AliceChief Legal Officer
IBEXIBEX Ltd
Open-market sale
SELL$93K
2,376 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

36
WH
Wang HaichenDirector, Chief Financial Officer
BULLWebull Corp
Open-market sale
SELL$494K
55.0K sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K